b Tested in sodium chloride 0.9%.
c Tested in Ringers injection, lactated.
e Injected via Y-site into an administration set running azithromycin.
f Final concentration after mixing.
g Tested in both dextrose 5% and sodium chloride 0.9%.
h Test performed using the Cubicin formulation.
i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
k Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.
l Tested in dextrose 5%, sodium chloride 0.9%, and Ringers injection, lactated.
m Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
n Tested as the premixed infusion solution.
o Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.